Biosion Initiates Phase II Clinical Trial of BSI-045B in Atopic Dermatitis

/PRNewswire/ -- Biosion USA, Inc. (Biosion), a global clinical-stage R&D biotechnology company, today announced that it has successfully opened an IND...

Related Keywords

China ,Australia ,Nanjing ,Jiangsu ,Hugh Davis ,Prnewswire Biosion United States Inc ,Drug Administration ,Biosion Inc ,United States ,Chief Operating Officer ,Biosion United ,Biosion ,Nc ,